EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative study between the efficacy of prabotulinum toxin‐A versus onabotulinum toxin‐A for the treatment of upper facial expression lines

Nicte Rodriguez-Chavez, Edric Gonzalez-Mondragón iD, Angel Nava-Castañeda iD

Journal of Cosmetic Dermatology · 2024

DOI: 10.1111/jocd.16454 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Nicte Rodriguez-Chavez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Oculoplastic Department, Instituto de Oftalmología, Fundación Conde de Valenciana F. A. P, Mexico City, Mexico. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Skin Aging, Facial Expression. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Botulinum Toxin (BoNTA) is the most used nonsurgical aesthetic procedure to treat facial expression lines.

Aims

This study compared the efficacy of Prabotulinum toxin‐A, a novel BoNTA that originates from Clostridium botulinum Hall‐A, with onabotulinum toxin‐A in treating facial expression lines using the Facial Wrinkle Scale (FWS) and FACE‐Q questionnaires.

Methods

This was an experimental, comparative, longitudinal, open‐label, and prospective study. Patients aged between 25 and 40 years with upper‐third facial expression lines were included. Follow‐ups were made at three, seven, 30, and 120 days.

Results

A total of 26 patients were included: 20 female, and six males, with a mean age of 28.26 years. An average of 31.00 IU and 31.38 IU were administered to the onabotulinum and prabotulinum groups, respectively. The prabotulinum group demonstrated superiority in FWS and Face‐Q scores between the first and third days ( p ≤ 0.001, p < 0.001, respectively), which continued on day 7. By day 30, there were no differences in the scores of the two questionnaires.

Conclusions

Prabotulinum toxin‐A is a safe and effective treatment for upper‐third facial wrinkles. On day three and seven, the results suggest that prabotulinum toxin‐A has a quicker onset of action than onabotulinum toxin‐A. On days 30 and 120, both groups showed similar FWS and Face‐Q scores.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ASkin AgingFacial ExpressionHumansFemaleAdultMaleProspective StudiesTreatment OutcomeCosmetic TechniquesNeuromuscular AgentsLongitudinal StudiesFacePatient Satisfaction

Stichwörter der Autor:innen

Botoxbotulinum toxinfacial wrinklesonabotulinumprabotulinum

Substanzen

Botulinum Toxins, Type Aonabotulinum toxin Aprabotulinumtoxin ANeuromuscular Agents

Autor:innen und Institutionen

  • Oculoplastic Department, Instituto de Oftalmología, Fundación Conde de Valenciana F. A. P, Mexico City, Mexico.

ORCID-Profile: Edric Gonzalez-Mondragón, Angel Nava-Castañeda

Zitieren

APA

Rodriguez-Chavez, N., Gonzalez-Mondragón, E., & Nava-Castañeda, A. (2024). Comparative study between the efficacy of prabotulinum toxin‐A versus onabotulinum toxin‐A for the treatment of upper facial expression lines. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16454

Vancouver

Rodriguez-Chavez N, Gonzalez-Mondragón E, Nava-Castañeda A. Comparative study between the efficacy of prabotulinum toxin‐A versus onabotulinum toxin‐A for the treatment of upper facial expression lines. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16454

BibTeX
@article{RodriguezChavez2024,
  author = {Rodriguez-Chavez, Nicte and Gonzalez-Mondragón, Edric and Nava-Castañeda, Angel},
  title = {Comparative study between the efficacy of prabotulinum toxin‐A versus onabotulinum toxin‐A for the treatment of upper facial expression lines},
  journal = {Journal of Cosmetic Dermatology},
  year = {2024},
  doi = {10.1111/jocd.16454}
}
Kostenlos starten →